Akik Parikh, MD
Cardiovascular Disease (Cardiology) · Modesto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital Manteca. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Parikh’s office at (209) 735-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A65494 · Current
Licensed to practise in California · since 1998 · expires 2028-02-29 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital MantecaManteca, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.172, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.303, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital Manteca
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 0 worse of 1 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.172 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.303 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.23 to 2.38) · 148 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.93 (0.47 to 1.39) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 14 · 128 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 2,759 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.04 to 0.51) · 723 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.74 (1.19 to 6.29) · 143 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.38) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.25 (0.55 to 3.95) · 130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.31 (0 to 17.9) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.1 (0.81 to 9.38) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 42 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.43 (0 to 1.53) · 576 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.56 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.616 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.53 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 205 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 662 cases | None | Jul 2023 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 472 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 22.2 · 277 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,942 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$2,849
Medicare paid this office $2,849 for 64 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 41 | $298 | $6 |
Who their Medicare patients are
64 Original Medicare patients in 2024. Average age 67 · Under 65 23% · Women 44% · Also on Medicaid 50% · Health risk score 2.57. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 42% · Coronary heart disease 41% · Heart failure 41% · Chronic kidney disease 38% · Depression 31% · COPD 27% · Atrial fibrillation 27%.
The office billed $16,540, Medicare allowed $4,365 and paid $2,849; for 106 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 64 | 106 | 67 | 2.57 | $16,540 | $2,849 |
| 2023 | 60 | 86 | 69 | 2.61 | $8,797 | $1,661 |
| 2022 | 55 | 81 | 66 | 2.34 | $11,563 | $2,429 |
| 2021 | 19 | 26 | 64 | 2.02 | $4,915 | $925 |
| 2019 | 86 | 318 | 80 | 1.76 | $105,691 | $26,045 |
| 2018 | 305 | 1,816 | 78 | 1.71 | $662,508 | $152,277 |
| 2017 | 373 | 2,245 | 78 | 1.85 | $840,899 | $192,467 |
| 2016 | 379 | 1,921 | 77 | 1.84 | $703,321 | $164,278 |
| 2015 | 412 | 2,806 | 76 | 1.65 | $729,763 | $188,594 |
| 2014 | 437 | 4,718 | 76 | 1.67 | $691,545 | $188,842 |
| 2013 | 414 | 1,998 | 76 | 1.58 | $480,760 | $182,350 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 41 | $299 | $6 |
2022: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 26 | $187 | $6 |
2021: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $109 | $6 |
2019: 10 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 19 | $9,572 | $504 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 14 | $3,714 | $68 |
| Injection, regadenoson, 0.1 mg | 16 | $2,896 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 19 | $2,320 | $97 |
| Return visit (30+ min) | 31 | $2,072 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 20 | $1,242 | $62 |
| Programming of dual lead pacemaker system | 15 | $616 | $41 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $393 | $20 |
| Short return visit (20+ min) | 11 | $358 | $33 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $231 | $11 |
2018: 17 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 83 | $41,637 | $502 |
| Return visit (30+ min) | 151 | $24,030 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 97 | $19,986 | $202 |
| Injection, regadenoson, 0.1 mg | 63 | $10,944 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 83 | $9,152 | $92 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 67 | $6,600 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 104 | $6,519 | $60 |
| New patient visit (45+ min) | 37 | $5,235 | $141 |
| Long return visit (40+ min) | 33 | $4,640 | $133 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 170 | $2,921 | $15 |
| Programming of dual lead pacemaker system | 33 | $2,507 | $46 |
| Short return visit (20+ min) | 37 | $2,266 | $61 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 101 | $2,177 | $21 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,916 | $120 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 25 | $1,580 | $63 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 20 | $1,558 | $78 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 11 | $570 | $52 |
2017: 19 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 110 | $53,107 | $478 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 136 | $29,282 | $209 |
| Return visit (30+ min) | 165 | $25,967 | $87 |
| Injection, regadenoson, 0.1 mg | 81 | $14,195 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 110 | $12,590 | $90 |
| New patient visit (45+ min) | 82 | $11,271 | $137 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 121 | $7,656 | $61 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 79 | $7,263 | $24 |
| Short return visit (20+ min) | 51 | $3,296 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 193 | $3,283 | $15 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,985 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 54 | $2,930 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,496 | $61 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 30 | $2,206 | $74 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 105 | $2,056 | $19 |
| Programming of dual lead pacemaker system | 25 | $1,907 | $48 |
| Long return visit (40+ min) | 13 | $1,528 | $118 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $208 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $139 | $13 |
2016: 18 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 80 | $38,117 | $476 |
| Return visit (30+ min) | 177 | $27,202 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 122 | $26,843 | $215 |
| Injection, regadenoson, 0.1 mg | 60 | $10,127 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 84 | $10,091 | $93 |
| New patient visit (45+ min) | 58 | $8,468 | $146 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 92 | $6,016 | $63 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 57 | $5,656 | $26 |
| Long return visit (40+ min) | 28 | $4,102 | $128 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 211 | $3,551 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 48 | $2,728 | $55 |
| Short return visit (20+ min) | 42 | $2,641 | $60 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 30 | $2,254 | $75 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,038 | $113 |
| Programming of dual lead pacemaker system | 29 | $1,931 | $47 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 96 | $1,722 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,112 | $62 |
| Blood glucose (sugar) test performed by hand-held instrument | 12 | $56 | $3 |
2015: 21 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 113 | $55,415 | $454 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 123 | $29,477 | $234 |
| Return visit (30+ min) | 168 | $27,214 | $100 |
| Injection, regadenoson, 0.1 mg | 61 | $9,475 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 64 | $9,280 | $131 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 124 | $9,242 | $69 |
| New patient visit (45+ min) | 59 | $8,659 | $147 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 62 | $3,902 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $3,455 | $128 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 183 | $3,378 | $17 |
| Short return visit (20+ min) | 45 | $3,293 | $69 |
| Long return visit (40+ min) | 21 | $3,163 | $132 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 35 | $2,272 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $2,241 | $68 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 98 | $2,092 | $20 |
| Programming of dual lead pacemaker system | 24 | $1,892 | $51 |
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 14 | $619 | None |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 24 | $599 | $22 |
| Electrocardiogram (ecg) 2-day continuous with report | 13 | $528 | $41 |
| Electrocardiogram (ecg) 2-day continuous | 13 | $292 | $22 |
| Blood glucose (sugar) test performed by hand-held instrument | 14 | $44 | $3 |
2014: 23 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 107 | $53,482 | $491 |
| Return visit (30+ min) | 168 | $25,693 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 97 | $21,818 | $220 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 100 | $17,006 | $132 |
| Injection, regadenoson, 0.1 mg | 49 | $7,971 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 120 | $7,849 | $64 |
| Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | 36 | $5,446 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 86 | $4,880 | $56 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 68 | $4,599 | $17 |
| New patient visit (45+ min) | 31 | $4,248 | $137 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,773 | $122 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 195 | $3,203 | $15 |
| Long return visit (40+ min) | 20 | $2,753 | $131 |
| Short return visit (20+ min) | 45 | $2,749 | $57 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 118 | $2,346 | $20 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,922 | $64 |
| Programming of dual lead pacemaker system | 27 | $1,881 | $49 |
| New patient visit (30+ min) | 13 | $1,257 | $97 |
| Electrocardiogram (ecg) 2-day continuous with report | 29 | $1,068 | $36 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 32 | $698 | $21 |
| Electrocardiogram (ecg) 2-day continuous | 29 | $631 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $283 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $182 | $13 |
2013: 23 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 91 | $48,026 | $511 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 173 | $32,025 | $180 |
| Return visit (30+ min) | 145 | $21,975 | $93 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 75 | $11,827 | $130 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 123 | $8,795 | $66 |
| Injection, adenosine for diagnostic use, 30 mg (not to be used to report any adenosine phosphate compounds; instead use a9270) | 31 | $7,555 | None |
| New patient visit (45+ min) | 45 | $6,686 | $149 |
| Injection, regadenoson, 0.1 mg | 36 | $6,049 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 72 | $4,039 | $55 |
| Short return visit (20+ min) | 61 | $4,014 | $59 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 58 | $3,267 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 175 | $3,218 | $17 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 113 | $2,333 | $19 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,260 | $119 |
| Programming of dual lead pacemaker system | 22 | $1,898 | $53 |
| Long return visit (40+ min) | 15 | $1,897 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,257 | $63 |
| New patient visit (30+ min) | 12 | $1,214 | $101 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 34 | $776 | $23 |
| Electrocardiogram (ecg) 2-day continuous with report | 22 | $750 | $34 |
| Electrocardiogram (ecg) 2-day continuous | 22 | $487 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $269 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $179 | $13 |
Medicaid work
$7,097 in 2024
Medicaid paid $7,097 for 613 billed services this clinician did in 2024, up to 106 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 593 | $6,979 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 20 | $118 |
| 2024 | 613 | 2 | 106 | $7,097 |
| 2023 | 236 | 1 | 48 | $2,206 |
| 2022 | 216 | 1 | 35 | $1,809 |
| 2021 | 114 | 1 | 25 | $813 |
| 2020 | 139 | 1 | 28 | $1,261 |
| 2019 | 41 | 1 | 19 | $308 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 236 | $2,206 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 216 | $1,809 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 114 | $813 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 139 | $1,261 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 41 | $308 |
Drugs they prescribed that Part D paid
$298,516
Pharmacies billed $298,516 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,259) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,076 generic and 183 brand-name prescriptions · $298,516 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 98 | $53,358 | $544 |
| Eliquis | 23 | $35,808 | $1,557 |
| Entresto | 21 | $28,744 | $1,369 |
| Pradaxa | 31 | $9,142 | $295 |
| Furosemide | 126 | $2,079 | $16 |
See all 25 drugs
| Jardiance | 98 | $53,358 | $544 |
| Eliquis | 23 | $35,808 | $1,557 |
| Entresto | 21 | $28,744 | $1,369 |
| Pradaxa | 31 | $9,142 | $295 |
| Furosemide | 126 | $2,079 | $16 |
| Amiodarone | 57 | $1,842 | $32 |
| Sotalol | 61 | $1,448 | $24 |
| Metoprolol | 78 | $1,165 | $15 |
| Losartan | 80 | $1,097 | $14 |
| Carvedilol | 75 | $905 | $12 |
| Atenolol | 71 | $870 | $12 |
| Metoprolol | 68 | $820 | $12 |
| Atorvastatin | 55 | $765 | $14 |
| Isosorbide Mononitrate Er | 41 | $748 | $18 |
| Clopidogrel | 36 | $717 | $20 |
| Lisinopril | 45 | $643 | $14 |
| Flecainide Acetate | 15 | $623 | $42 |
| Potassium Chloride | 26 | $595 | $23 |
| Diltiazem 24hr Er (Cd) | 14 | $465 | $33 |
| Verapamil Er | 14 | $455 | $33 |
| Spironolactone | 48 | $452 | $9 |
| Hydralazine | 16 | $405 | $25 |
| Amlodipine Besylate | 29 | $365 | $13 |
| Nitroglycerin | 18 | $285 | $16 |
| Hydrochlorothiazide | 15 | $175 | $12 |
Year by year
| 2024 | 1,259 | 342 | 0% (0) | 15% | $298,516 |
| 2023 | 1,109 | 292 | 0% (0) | 18% | $114,899 |
| 2022 | 1,091 | 287 | 0% (0) | 23% | $98,656 |
| 2021 | 766 | 215 | 0% (0) | 21% | $57,549 |
| 2020 | 619 | 163 | 0% (0) | 20% | $40,619 |
| 2019 | 1,956 | 472 | 0% (0) | 22% | $197,635 |
| 2018 | 3,994 | 581 | 0% (0) | 21% | $387,370 |
| 2017 | 4,196 | 610 | 0% (0) | 21% | $312,415 |
| 2016 | 4,021 | 565 | None | 19% | $255,391 |
| 2015 | 3,391 | 511 | None | 16% | $167,862 |
| 2014 | 3,407 | 496 | 0% (0) | 16% | $128,266 |
| 2013 | 3,432 | 501 | 0% (0) | 18% | $125,380 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Jardiance | 70 | $52,173 | $745 |
| Entresto | 12 | $15,457 | $1,288 |
| Eliquis | 13 | $13,247 | $1,019 |
| Pradaxa | 35 | $11,069 | $316 |
| Furosemide | 124 | $2,061 | $17 |
| Amiodarone | 52 | $1,738 | $33 |
| Atorvastatin | 88 | $1,636 | $19 |
| Metoprolol | 62 | $1,236 | $20 |
| Lisinopril | 63 | $962 | $15 |
| Potassium Chloride | 25 | $941 | $38 |
| Losartan | 64 | $914 | $14 |
| Ranolazine Er | 13 | $872 | $67 |
| Atenolol | 70 | $829 | $12 |
| Diltiazem 24hr Er (Cd) | 35 | $764 | $22 |
| Metoprolol | 62 | $760 | $12 |
| Sotalol | 32 | $746 | $23 |
| Carvedilol | 42 | $538 | $13 |
| Isosorbide Mononitrate Er | 33 | $504 | $15 |
| Rosuvastatin | 20 | $491 | $25 |
| Flecainide Acetate | 12 | $470 | $39 |
| Amlodipine Besylate | 31 | $418 | $13 |
| Hydrochlorothiazide | 29 | $352 | $12 |
| Clopidogrel | 14 | $275 | $20 |
| Spironolactone | 20 | $195 | $10 |
2022: 23 drugs
| Jardiance | 40 | $25,482 | $637 |
| Pradaxa | 28 | $15,391 | $550 |
| Eliquis | 11 | $14,931 | $1,357 |
| Furosemide | 147 | $2,416 | $16 |
| Amiodarone | 49 | $1,841 | $38 |
| Atorvastatin | 86 | $1,618 | $19 |
| Ranolazine Er | 18 | $1,360 | $76 |
| Metoprolol | 84 | $973 | $12 |
| Lisinopril | 61 | $945 | $15 |
| Metoprolol | 42 | $937 | $22 |
| Rosuvastatin | 38 | $888 | $23 |
| Atenolol | 67 | $869 | $13 |
| Flecainide Acetate | 18 | $837 | $46 |
| Losartan | 53 | $772 | $15 |
| Sotalol | 28 | $760 | $27 |
| Potassium Chloride | 28 | $665 | $24 |
| Diltiazem 24hr Er (Cd) | 22 | $564 | $26 |
| Isosorbide Mononitrate Er | 23 | $489 | $21 |
| Amlodipine Besylate | 37 | $465 | $13 |
| Hydrochlorothiazide | 39 | $452 | $12 |
| Carvedilol | 27 | $287 | $11 |
| Clopidogrel | 14 | $283 | $20 |
| Spironolactone | 23 | $216 | $9 |
2021: 20 drugs
| Eliquis | 20 | $19,277 | $964 |
| Pradaxa | 27 | $18,433 | $683 |
| Furosemide | 97 | $1,410 | $15 |
| Diltiazem 24hr Er (Xr) | 22 | $1,057 | $48 |
| Atorvastatin | 60 | $1,028 | $17 |
| Metoprolol | 42 | $1,015 | $24 |
| Amiodarone | 23 | $844 | $37 |
| Lisinopril | 57 | $785 | $14 |
| Flecainide Acetate | 17 | $740 | $44 |
| Atenolol | 62 | $710 | $11 |
| Losartan | 35 | $484 | $14 |
| Hydrochlorothiazide | 36 | $447 | $12 |
| Amlodipine Besylate | 34 | $420 | $12 |
| Rosuvastatin | 16 | $418 | $26 |
| Metoprolol | 39 | $415 | $11 |
| Sotalol | 11 | $403 | $37 |
| Clopidogrel | 13 | $258 | $20 |
| Isosorbide Mononitrate Er | 19 | $243 | $13 |
| Spironolactone | 18 | $178 | $10 |
| Carvedilol | 14 | $160 | $11 |
2020: 16 drugs
| Eliquis | 16 | $17,173 | $1,073 |
| Pradaxa | 15 | $9,536 | $636 |
| Atorvastatin | 88 | $1,582 | $18 |
| Dilt-Xr | 16 | $1,108 | $69 |
| Amiodarone | 23 | $867 | $38 |
| Furosemide | 69 | $865 | $13 |
| Lisinopril | 61 | $806 | $13 |
| Metoprolol | 20 | $514 | $26 |
| Metoprolol | 42 | $442 | $11 |
| Atenolol | 41 | $425 | $10 |
| Amlodipine Besylate | 32 | $360 | $11 |
| K-Tab Er | 14 | $359 | $26 |
| Hydrochlorothiazide | 28 | $337 | $12 |
| Losartan | 25 | $296 | $12 |
| Carvedilol | 22 | $240 | $11 |
| Spironolactone | 12 | $184 | $15 |
2019: 30 drugs
| Eliquis | 128 | $80,918 | $632 |
| Xarelto | 73 | $50,659 | $694 |
| Pradaxa | 19 | $9,697 | $510 |
| Ranexa | 11 | $9,293 | $845 |
| Atorvastatin | 171 | $4,049 | $24 |
| Diltiazem 24hr Er (Cd) | 30 | $3,425 | $114 |
| Furosemide | 189 | $2,579 | $14 |
| Lisinopril | 154 | $2,112 | $14 |
| Potassium Chloride | 52 | $1,984 | $38 |
| Metoprolol | 130 | $1,964 | $15 |
| Metoprolol | 58 | $1,848 | $32 |
| Amlodipine Besylate | 137 | $1,662 | $12 |
| Isosorbide Mononitrate Er | 42 | $1,453 | $35 |
| Diltiazem 24hr Er | 33 | $1,251 | $38 |
| Atenolol | 89 | $1,126 | $13 |
| Carvedilol | 76 | $1,056 | $14 |
| Clopidogrel | 48 | $993 | $21 |
| Hydrochlorothiazide | 85 | $955 | $11 |
| Simvastatin | 59 | $908 | $15 |
| Digoxin | 21 | $883 | $42 |
| Losartan | 57 | $803 | $14 |
| Valsartan-Hydrochlorothiazide | 13 | $775 | $60 |
| Pravastatin | 26 | $650 | $25 |
| Nitroglycerin | 19 | $553 | $29 |
| Hydralazine | 12 | $468 | $39 |
| Spironolactone | 20 | $447 | $22 |
| Amiodarone | 16 | $427 | $27 |
| Lisinopril-Hydrochlorothiazide | 21 | $322 | $15 |
| Losartan-Hydrochlorothiazide | 17 | $293 | $17 |
| Benazepril | 18 | $239 | $13 |
2018: 41 drugs
| Xarelto | 199 | $124,149 | $624 |
| Eliquis | 204 | $120,464 | $591 |
| Ranexa | 50 | $34,110 | $682 |
| Pradaxa | 15 | $14,293 | $953 |
| Atorvastatin | 319 | $10,315 | $32 |
| Lisinopril | 325 | $5,949 | $18 |
| Diltiazem 24hr Er (Cd) | 41 | $4,896 | $119 |
| Metoprolol | 94 | $4,472 | $48 |
| Furosemide | 399 | $4,323 | $11 |
| Amlodipine Besylate | 244 | $3,987 | $16 |
| Bumetanide | 26 | $3,521 | $135 |
| Metoprolol | 254 | $3,372 | $13 |
| Isosorbide Mononitrate Er | 92 | $3,293 | $36 |
| Potassium Chloride | 89 | $3,232 | $36 |
| Carvedilol | 192 | $3,133 | $16 |
| Clopidogrel | 116 | $2,701 | $23 |
| Simvastatin | 139 | $2,481 | $18 |
| Hydralazine | 53 | $2,362 | $45 |
| Diltiazem 24hr Er | 44 | $2,262 | $51 |
| Atenolol | 152 | $2,250 | $15 |
| Pravastatin | 52 | $1,691 | $33 |
| Digoxin | 31 | $1,673 | $54 |
| Digox | 27 | $1,585 | $59 |
| Nitroglycerin | 49 | $1,579 | $32 |
| Losartan | 107 | $1,476 | $14 |
| Hydrochlorothiazide | 186 | $1,461 | $8 |
| Valsartan | 30 | $1,178 | $39 |
| Midodrine | 16 | $1,072 | $67 |
| Dilt-Xr | 17 | $900 | $53 |
| Spironolactone | 39 | $814 | $21 |
| Valsartan-Hydrochlorothiazide | 22 | $728 | $33 |
| Amiodarone | 27 | $718 | $27 |
| Losartan-Hydrochlorothiazide | 46 | $664 | $14 |
| Omeprazole | 25 | $663 | $27 |
| Lisinopril-Hydrochlorothiazide | 39 | $566 | $15 |
| Cartia Xt | 16 | $560 | $35 |
| Benazepril | 31 | $491 | $16 |
| Clonidine | 15 | $316 | $21 |
| Klor-Con 10 | 11 | $174 | $16 |
| Warfarin | 11 | $152 | $14 |
| Sotalol | 13 | $135 | $10 |
2017: 40 drugs
| Xarelto | 175 | $106,881 | $611 |
| Eliquis | 132 | $68,367 | $518 |
| Ranexa | 51 | $35,450 | $695 |
| Pradaxa | 16 | $15,026 | $939 |
| Atorvastatin | 339 | $7,704 | $23 |
| Metoprolol | 98 | $6,405 | $65 |
| Bumetanide | 28 | $4,253 | $152 |
| Furosemide | 414 | $3,184 | $8 |
| Isosorbide Mononitrate Er | 102 | $3,035 | $30 |
| Lisinopril | 323 | $2,893 | $9 |
| Diltiazem 24hr Er | 70 | $2,727 | $39 |
| Metoprolol | 278 | $2,395 | $9 |
| Potassium Chloride | 79 | $2,281 | $29 |
| Carvedilol | 198 | $2,277 | $12 |
| Digox | 51 | $2,225 | $44 |
| Amlodipine Besylate | 301 | $2,039 | $7 |
| Clopidogrel | 92 | $1,838 | $20 |
| Nitroglycerin | 56 | $1,821 | $33 |
| Pravastatin | 54 | $1,738 | $32 |
| Simvastatin | 189 | $1,613 | $9 |
| Atenolol | 185 | $1,608 | $9 |
| Valsartan | 44 | $1,442 | $33 |
| Digoxin | 22 | $1,342 | $61 |
| Hydrochlorothiazide | 185 | $1,334 | $7 |
| Midodrine | 18 | $1,240 | $69 |
| Amiodarone | 34 | $1,120 | $33 |
| Losartan | 87 | $1,081 | $12 |
| Valsartan-Hydrochlorothiazide | 28 | $826 | $29 |
| Hydralazine | 50 | $821 | $16 |
| Spironolactone | 54 | $808 | $15 |
| Losartan-Hydrochlorothiazide | 51 | $607 | $12 |
| Dilt-Xr | 18 | $572 | $32 |
| Lisinopril-Hydrochlorothiazide | 53 | $532 | $10 |
| Benazepril | 44 | $524 | $12 |
| Digitek | 13 | $428 | $33 |
| Diltiazem | 21 | $390 | $19 |
| Taztia Xt | 11 | $362 | $33 |
| Sotalol | 21 | $288 | $14 |
| Clonidine | 17 | $169 | $10 |
| Klor-Con 10 | 15 | $152 | $10 |
2016: 45 drugs
| Xarelto | 179 | $86,643 | $484 |
| Eliquis | 80 | $32,184 | $402 |
| Ranexa | 43 | $26,436 | $615 |
| Pradaxa | 20 | $13,247 | $662 |
| Atorvastatin | 267 | $6,707 | $25 |
| Diltiazem 24hr Er | 57 | $5,705 | $100 |
| Valsartan | 72 | $4,506 | $63 |
| Lisinopril | 344 | $4,233 | $12 |
| Bumetanide | 48 | $3,970 | $83 |
| Furosemide | 327 | $3,525 | $11 |
| Digox | 47 | $3,430 | $73 |
| Metoprolol | 271 | $3,299 | $12 |
| Isosorbide Mononitrate Er | 98 | $3,047 | $31 |
| Omega-3 Acid Ethyl Esters | 11 | $3,037 | $276 |
| Potassium Chloride | 92 | $3,006 | $33 |
| Metoprolol | 66 | $2,871 | $44 |
| Clonidine | 18 | $2,804 | $156 |
| Carvedilol | 179 | $2,789 | $16 |
| Amlodipine Besylate | 308 | $2,591 | $8 |
| Simvastatin | 209 | $2,420 | $12 |
| Digoxin | 39 | $2,255 | $58 |
| Clopidogrel | 69 | $2,131 | $31 |
| Amiodarone | 51 | $2,053 | $40 |
| Hydralazine | 50 | $2,023 | $40 |
| Atenolol | 233 | $1,917 | $8 |
| Pravastatin | 49 | $1,821 | $37 |
| Hydrochlorothiazide | 190 | $1,391 | $7 |
| Taztia Xt | 27 | $1,335 | $49 |
| Nitrostat | 33 | $1,248 | $38 |
| Digitek | 16 | $1,187 | $74 |
| Dilt-Xr | 18 | $1,053 | $58 |
| Losartan | 82 | $996 | $12 |
| Metolazone | 13 | $744 | $57 |
| Spironolactone | 33 | $717 | $22 |
| Losartan-Hydrochlorothiazide | 37 | $621 | $17 |
| Amlodipine Besylate-Benazepril | 16 | $608 | $38 |
| Valsartan-Hydrochlorothiazide | 19 | $604 | $32 |
| Lisinopril-Hydrochlorothiazide | 48 | $598 | $12 |
| Cartia Xt | 15 | $549 | $37 |
| Benazepril | 35 | $473 | $14 |
| Sotalol | 21 | $403 | $19 |
| Klor-Con 10 | 16 | $314 | $20 |
| Warfarin | 21 | $284 | $14 |
| Cilostazol | 12 | $267 | $22 |
| Omeprazole | 14 | $187 | $13 |
2015: 42 drugs
| Xarelto | 83 | $33,792 | $407 |
| Ranexa | 23 | $18,390 | $800 |
| Eliquis | 31 | $12,621 | $407 |
| Valsartan | 49 | $5,783 | $118 |
| Atorvastatin | 199 | $5,766 | $29 |
| Lisinopril | 421 | $5,426 | $13 |
| Diltiazem 24hr Er | 39 | $4,833 | $124 |
| Omega-3 Acid Ethyl Esters | 13 | $4,098 | $315 |
| Bumetanide | 49 | $3,820 | $78 |
| Digox | 31 | $3,352 | $108 |
| Furosemide | 284 | $3,080 | $11 |
| Potassium Chloride | 70 | $2,800 | $40 |
| Clopidogrel | 103 | $2,767 | $27 |
| Clonidine | 13 | $2,548 | $196 |
| Isosorbide Mononitrate Er | 87 | $2,545 | $29 |
| Metoprolol | 224 | $2,296 | $10 |
| Pravastatin | 51 | $2,278 | $45 |
| Digoxin | 36 | $2,275 | $63 |
| Carvedilol | 155 | $2,133 | $14 |
| Simvastatin | 164 | $1,865 | $11 |
| Metoprolol | 39 | $1,814 | $47 |
| Amlodipine Besylate | 255 | $1,813 | $7 |
| Hydralazine | 38 | $1,422 | $37 |
| Amiodarone | 72 | $1,336 | $19 |
| Hydrochlorothiazide | 137 | $1,271 | $9 |
| Atenolol | 187 | $1,263 | $7 |
| Diltiazem Er | 23 | $1,077 | $47 |
| Taztia Xt | 12 | $1,064 | $89 |
| Digitek | 11 | $1,047 | $95 |
| Cartia Xt | 20 | $864 | $43 |
| Losartan | 78 | $745 | $10 |
| Metolazone | 19 | $737 | $39 |
| Dilt-Xr | 13 | $689 | $53 |
| Benazepril | 44 | $550 | $12 |
| Spironolactone | 26 | $503 | $19 |
| Nitrostat | 20 | $415 | $21 |
| Lisinopril-Hydrochlorothiazide | 46 | $413 | $9 |
| Sotalol | 22 | $336 | $15 |
| Warfarin | 26 | $302 | $12 |
| Losartan-Hydrochlorothiazide | 12 | $260 | $22 |
| Klor-Con 10 | 14 | $250 | $18 |
| Omeprazole | 11 | $135 | $12 |
2014: 40 drugs
| Diovan | 45 | $15,171 | $337 |
| Ranexa | 25 | $14,213 | $569 |
| Pradaxa | 13 | $10,007 | $770 |
| Atorvastatin | 218 | $7,587 | $35 |
| Lisinopril | 420 | $6,102 | $15 |
| Valsartan | 14 | $4,699 | $336 |
| Lovaza | 14 | $4,362 | $312 |
| Metoprolol | 65 | $3,884 | $60 |
| Isosorbide Mononitrate Er | 104 | $3,180 | $31 |
| Digox | 54 | $2,842 | $53 |
| Potassium Chloride | 42 | $2,776 | $66 |
| Furosemide | 256 | $2,724 | $11 |
| Carvedilol | 167 | $2,499 | $15 |
| Metoprolol | 221 | $2,487 | $11 |
| Clopidogrel | 56 | $2,238 | $40 |
| Diltiazem 24hr Er | 43 | $2,184 | $51 |
| Bumetanide | 56 | $2,164 | $39 |
| Pravastatin | 52 | $2,153 | $41 |
| Simvastatin | 153 | $2,142 | $14 |
| Amlodipine Besylate | 279 | $1,948 | $7 |
| Digoxin | 33 | $1,799 | $55 |
| Atenolol | 200 | $1,679 | $8 |
| Diltiazem Er | 22 | $1,359 | $62 |
| Hydralazine | 26 | $1,239 | $48 |
| Valsartan-Hydrochlorothiazide | 14 | $1,213 | $87 |
| Hydrochlorothiazide | 139 | $1,184 | $9 |
| Benazepril | 53 | $858 | $16 |
| Amiodarone | 57 | $821 | $14 |
| Losartan | 81 | $805 | $10 |
| Lisinopril-Hydrochlorothiazide | 91 | $801 | $9 |
| Spironolactone | 43 | $772 | $18 |
| Klor-Con 10 | 27 | $601 | $22 |
| Sotalol | 24 | $595 | $25 |
| Warfarin | 58 | $557 | $10 |
| Cartia Xt | 15 | $527 | $35 |
| Nitrostat | 23 | $421 | $18 |
| Losartan-Hydrochlorothiazide | 17 | $376 | $22 |
| Propafenone | 12 | $372 | $31 |
| Klor-Con 8 | 11 | $302 | $27 |
| Cilostazol | 12 | $147 | $12 |
2013: 37 drugs
| Diovan | 88 | $17,911 | $204 |
| Pradaxa | 37 | $16,003 | $433 |
| Atorvastatin | 204 | $9,255 | $45 |
| Ranexa | 11 | $6,872 | $625 |
| Diltiazem 24hr Er | 78 | $6,308 | $81 |
| Lisinopril | 418 | $5,569 | $13 |
| Lovaza | 28 | $5,563 | $199 |
| Metoprolol | 58 | $3,793 | $65 |
| Metoprolol | 253 | $3,037 | $12 |
| Carvedilol | 174 | $2,974 | $17 |
| Isosorbide Mononitrate Er | 97 | $2,880 | $30 |
| Clopidogrel | 37 | $2,495 | $67 |
| Furosemide | 258 | $2,482 | $10 |
| Amlodipine Besylate | 289 | $2,348 | $8 |
| Potassium Chloride | 36 | $2,272 | $63 |
| Diovan Hct | 15 | $2,222 | $148 |
| Diltiazem Er | 42 | $2,209 | $53 |
| Simvastatin | 141 | $2,155 | $15 |
| Hydrochlorothiazide | 199 | $1,903 | $10 |
| Atenolol | 241 | $1,878 | $8 |
| Valsartan-Hydrochlorothiazide | 17 | $1,663 | $98 |
| Pravastatin | 41 | $1,592 | $39 |
| Losartan | 87 | $1,218 | $14 |
| Taztia Xt | 14 | $1,184 | $85 |
| Lisinopril-Hydrochlorothiazide | 81 | $874 | $11 |
| Benazepril | 38 | $794 | $21 |
| Digox | 75 | $722 | $10 |
| Amiodarone | 30 | $630 | $21 |
| Spironolactone | 31 | $613 | $20 |
| Losartan-Hydrochlorothiazide | 30 | $587 | $20 |
| Klor-Con 10 | 23 | $497 | $22 |
| Cilostazol | 18 | $486 | $27 |
| Hydralazine | 15 | $411 | $27 |
| Warfarin | 38 | $333 | $9 |
| Metolazone | 20 | $263 | $13 |
| Klor-Con 8 | 11 | $213 | $19 |
| Clonidine | 11 | $163 | $15 |
Money from drug and device companies
$45 in 2022
| 2022 | 1 | 1 | None | $45 |
| 2019 | 1 | 1 | None | $40 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Vyndamax | $45 | 1 payment
|
See the published payment
| Pfizer | Meals · 2022-04-13 | Vyndamax | $45 |
See earlier years (2019)
2019: $40
| Medtronic Vascular | Reveal Linq | $40 | 1 payment
|
Professional record
- NPI
- 1578674149
- Licence
- CA A65494California A65494: Current · expires 2028-02-29
- Trained
- New York Medical College, 1996
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 400 Race St, San Jose, CA, 95126
- NPI first listed
- 2006-08-31
- NPI last updated
- 2021-12-17
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.